stockrowCognex Corporation
CGNX Technology Scientific & Technical Instruments
Cognex Corporation’s revenue for fiscal 2025 (year ended December 2025) was $994.4 million, up 8.73% from fiscal 2024.
- Revenue
- +16.9%
- EPS
- +79.2%
- Free cash flow
- +67.3%
Quarter to June 2026, against a year earlier
Follow CGNX
Alert me
Cognex Corporation (CGNX) EPS (diluted)
Cognex Corporation's EPS (diluted) for fiscal 2025 was $0.68, up 9.68% from $0.62 in fiscal 2024. Over the twelve months to 30 June 2026 it was $1.03. Over the past ten years it has ranged from $0.62 (fiscal 2024) to $1.56 (fiscal 2021); the current reading is higher than 27% of that period. Cognex Corporation ranks 14th of 32 Scientific & Technical Instruments companies by EPS (diluted).
EPS (diluted), annual
Embed this chart
Annual newest first
| Period | EPS (diluted) | Change |
|---|---|---|
| FY2025 | $0.68 | 9.68% |
| FY2024 | $0.62 | (4.62%) |
| FY2023 | $0.65 | (47.15%) |
| FY2022 | $1.23 | (21.15%) |
| FY2021 | $1.56 | 56.00% |
| FY2020 | $1.00 | (13.79%) |
| FY2019 | $1.16 | (6.45%) |
| FY2018 | $1.24 | 25.25% |
| FY2017 | $0.99 | 15.12% |
| FY2016 | $0.86 | (19.25%) |
Quarterly newest first
| Period | EPS (diluted) | Change |
|---|---|---|
| Jun 2026 | $0.43 | 38.71% |
| Mar 2026 | $0.31 | 63.16% |
| Dec 2025 | $0.19 | 90.00% |
| Sep 2025 | $0.10 | (58.33%) |
| 42 more quarters | Free account |
Against its own ten years
EPS (diluted) against peers
| Company | EPS (diluted) |
|---|---|
| ESE ESCO Technologies Inc. compare | $12.14 |
| MKSI MKS Inc. compare | $6.27 |
| BMI Badger Meter, Inc. compare | $4.33 |
| ST Sensata Technologies Holding N.V. compare | $2.50 |
| VNT Vontier Corporation compare | $2.41 |
| FTV Fortive Corporation compare | $2.10 |
| NOVT Novanta Inc. compare | $1.56 |
| CGNX Cognex Corporation | $1.03 |
| TRMB Trimble Inc. compare | −$0.49 |
What EPS (diluted) is
Diluted EPS tells an investor how much profit a company earned for each share, counting the extra shares that options and convertible securities could create.
Reported line item
More on CGNX
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement